Molecular pharmacological study on he roles of brain cytokines in narcotic dependence
| Project/Area Number |
07457538
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | KYOTO UNIVERSITY |
|---|
Principal Investigator |
SATOH Masamichi Kyoto University, Faculty of Pharmaceutical Science, Professor, 薬学部, 教授 (80025709)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
MINAMI Masabumi Kyoto University, Faculty of Pharmaceutical Sciences, Instructor, 薬学部, 助手 (20243040)
|
|---|
| Project Period (FY) |
1995 – 1996
|
| Project Status |
Completed (Fiscal Year 1996)
|
| Budget Amount *help |
¥7,600,000 (Direct Cost: ¥7,600,000)
Fiscal Year 1996: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 1995: ¥6,300,000 (Direct Cost: ¥6,300,000)
|
|---|
| Keywords | morphine / narcotics / dependence / cytokines / interleukins / microglia / neuro-immune interaction / インターロイキン |
|---|
| Research Abstract |
Intracisternal injection of interleukin-1beta was shown to suppress naloxone-precipitated with-drawal syndrome in morphine dependent mouse. This effect of interleukin-1beta was mediated by CRF and prostaglandin E2. In order to clarify the target cells for interleukin-1beta in the brain, we visualized the cells expressing type 1 and type 2 interleukin-1 receptors using an in situ hybridization technique. In morphine-dependent mouse, prostaglandin E2 suppressed the withdrawal syndrome through EP3 receptors. Prostaglandin EP3 agonists suppressed the withdrawal syndrome also in the morphine-dependent rats, and attenuated the experssion of c-fos mRNA in various brain regions including the locus ceruleus. Double in situ hybridization study revealed that most of the tyrosine hydroxylase mRNA-positive neurons in the locus ceruleus expressed mu-opioid receptor mRNA and more than half of those neurons were positive to EP3 receptor mRNA,indicating that an EP3 agonist acts on the locus ceruleus noradrenergic neurons expressing mu-opioid receptors. EP3 agonists possibly suppress the excitation of the locus ceruleus noradrenergic neurons to inhibit the morphine withdrawal syndrome precipitated by naloxone.
|
Report
(3 results)
Research Products
(20 results)
